| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 20 | 4 | |
| Lung cancer | 2 | 0 | |
| Non-small cell lung cancer | 2 | 0 | |
| Typical lung carcinoid tumor | 2 | 0 | |
| Adenosquamous carcinoma (non-small cell lung cancer) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Diarrhea | 1 | |
| Nausea | 1 | |
| Prolonged QT interval | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 2 | |
| Moderate | 2 | |
| Mild | 0 | |
| None | 0 |